Citations

Clear

2 citation(s) found for "Senagore, A J".

Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Viscusi, Eugene R. , Wolff, Bruce G., Delaney, Conor P. , Senagore, Anthony J. , Techner, Lee, LUDWIG, KIRK A.

Mayo Clinic

World Journal of Surgery | June 4, 2010 | Volume: 34 | Issue: 9 | Pages: 2185-2190

10.1007/s00268-010-0635-9 | PMID 20526599 Get It

AbstractBackgroundA pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu‐opioid receptor (PAM‐OR) antagonist, for the management of postoperative ileus after bowel resection.MethodsAdult patients who underwent laparotomy for bowel resection scheduled for opioid‐based intravenous patient‐controlled analgesia received oral alvimopan or placebo preoperatively and twice daily postoperatively until hospital discharge or for 7 postoperative days. The proportion of responders and numbers needed to treat (NNT) were examined on postoperative days (POD) 3–8 for GI‐2 recovery (first bowel movement, toleration of solid food) and hospital discharge order (DCO) written.ResultsAlvimopan significantly increased the proportion of patients with GI‐2 recovery and DCO written by each POD (P < 0.001 for all). More patients who received alvimopan achieved GI‐2 recovery on or before POD 5 (alvimopan, 80%; placebo, 66%) and DCO written before POD 7 (alvimopan, 87%; placebo, 72%), with corresponding NNTs equal to 7.ConclusionsOn each POD analyzed, alvimopan significantly increased the proportion of patients who achieved GI‐2 recovery and DCO written versus placebo and was associated with relatively low NNTs. The results of these analyses provide additional characterization and support for the overall clinical benefit of alvimopan in patients undergoing bowel resection.
Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation
Lyford, Greg, He, C-L, Soffer, E, Hull, T L, Strong, S A, Senagore, A J, Burgart, L J, Young-Fadok, T, Szurszewski, J H, Farrugia, G, He, C-L, Soffer, E, Hull, T L, Strong, S A, Senagore, A J, Burgart, L J, Young-Fadok, T, Szurszewski, J H, Farrugia, G

Mayo Clinic

Gut | September 16, 2002 | Volume: 51 | Issue: 4 | Pages: 496-501

10.1136/gut.51.4.496 | PMID 12235070 Get It

Background: Interstitial cells of Cajal (ICC) are required for normal intestinal motility. ICC are found throughout the human colon and are decreased in the sigmoid colon of patients with slow transit constipation. Aims: The aims of this study were to determine the normal distribution of ICC within the human colon and to determine if ICC are decreased throughout the colon in slow transit constipation. Patients: The caecum, ascending, transverse, and sigmoid colons from six patients with slow transit constipation and colonic tissue from patients with resected colon cancer were used for this study. Methods: ICC cells were identified with a polyclonal antibody to c-Kit, serial 0.5 μm sections were obtained by confocal microscopy, and three dimensional software was employed to reconstruct the entire thickness of the colonic muscularis propria and submucosa. Results: ICC were located within both the longitudinal and circular muscle layers. Two networks of ICC were identified, one in the myenteric plexus region and another, less defined network, in the submucosal border. Caecum, ascending colon, transverse colon, and sigmoid colon displayed similar ICC volumes. ICC volume was significantly lower in the slow transit constipation patients across all colonic regions. Conclusions: The data suggest that ICC distribution is relatively uniform throughout the human colon and that decreased ICC volume is pan-colonic in idiopathic slow transit constipation.